Literature DB >> 12719691

Measuring the quality of depression care in a large integrated health system.

Andrea Charbonneau1, Amy K Rosen, Arlene S Ash, Richard R Owen, Boris Kader, Avron Spiro, Cheryl Hankin, Lawrence R Herz, Mary Jo V Pugh, Lewis Kazis, Donald R Miller, Dan R Berlowitz.   

Abstract

BACKGROUND: Guideline-based depression process measures provide a powerful way to monitor depression care and target areas needing improvement.
OBJECTIVES: To assess the adequacy of depression care in the Veterans Health Administration (VHA) using guideline-based process measures derived from administrative and centralized pharmacy records, and to identify patient and provider characteristics associated with adequate depression care. RESEARCH
DESIGN: This is a cohort study of patients from 14 VHA hospitals in the Northeastern United States which relied on existing databases. Subject eligibility criteria: at least one depression diagnosis during 1999, neither schizophrenia nor bipolar disease, and at least one antidepressant prescribed in the VHA during the period of depression care profiling (June 1, 1999 through August 31, 1999). Depression care was evaluated with process measures defined from the 1997 VHA depression guidelines: antidepressant dosage and duration adequacy. We used multivariable regression to identify patient and provider characteristics predicting adequate care.
SUBJECTS: There were 12,678 patients eligible for depression care profiling.
RESULTS: Adequate dosage was identified in 90%; 45% of patients had adequate duration of antidepressants. Significant patient and provider characteristics predicting inadequate depression care were younger age (<65), black race, and treatment exclusively in primary care.
CONCLUSIONS: Under-treatment of depression exists in the VHA, despite considerable mental health access and generous pharmacy benefits. Certain patient populations may be at higher risk for inadequate depression care. More work is needed to align current practice with best-practice guidelines and to identify optimal ways of using available data sources to monitor depression care quality.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719691     DOI: 10.1097/01.MLR.0000062920.51692.B4

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  37 in total

1.  Ten-year trends in quality of care and spending for depression: 1996 through 2005.

Authors:  Catherine A Fullerton; Alisa B Busch; Sharon-Lise T Normand; Thomas G McGuire; Arnold M Epstein
Journal:  Arch Gen Psychiatry       Date:  2011-12

Review 2.  Drug utilization review across jurisdictions--a reality or still a distant dream?

Authors:  Lisa K Pulver; Susan E Tett
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

Review 3.  Racial disparities in diagnosis and treatment of depression: a literature review.

Authors:  Sherri M Simpson; Laura L Krishnan; Mark E Kunik; Pedro Ruiz
Journal:  Psychiatr Q       Date:  2007-03

4.  Pre-post evaluation of automated reminders may improve detection and management of post-stroke depression.

Authors:  Linda S Williams; Susan Ofner; Zhangsheng Yu; Rebecca J Beyth; Laurie Plue; Teresa Damush
Journal:  J Gen Intern Med       Date:  2011-08       Impact factor: 5.128

5.  Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings.

Authors:  Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Michael Rodriguez; Richard S Baker
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

6.  Discontinuation of antidepressant medication among Latinos in the USA.

Authors:  Dominic Hodgkin; Joanna Volpe-Vartanian; Margarita Alegría
Journal:  J Behav Health Serv Res       Date:  2007-06-15       Impact factor: 1.505

7.  Improving secondary stroke self-care among underserved ethnic minority individuals: a randomized clinical trial of a pilot intervention.

Authors:  Gina L Evans-Hudnall; Melinda A Stanley; Allison N Clark; Amber L Bush; Ken Resnicow; Yu Liu; Joseph S Kass; Angelle M Sander
Journal:  J Behav Med       Date:  2012-12-08

8.  Organizational cost of quality improvement for depression care.

Authors:  Chuan-Fen Liu; Lisa V Rubenstein; JoAnn E Kirchner; John C Fortney; Mark W Perkins; Scott K Ober; Jeffrey M Pyne; Edmund F Chaney
Journal:  Health Serv Res       Date:  2009-02       Impact factor: 3.402

9.  Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Greer Sullivan
Journal:  J Subst Abuse Treat       Date:  2016-06-07

10.  Access to adequate outpatient depression care for mothers in the USA: a nationally representative population-based study.

Authors:  Whitney P Witt; Abiola Keller; Carissa Gottlieb; Kristin Litzelman; John Hampton; Jonathan Maguire; Erika W Hagen
Journal:  J Behav Health Serv Res       Date:  2009-10-17       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.